What is Aclaris Therapeutics's net change in cash?

Aclaris Therapeutics (ACRS) reported net change in cash of $8.7M in Q1 2026.

How has Aclaris Therapeutics's net change in cash changed year-over-year?

Aclaris Therapeutics's net change in cash increased by 50.3% year-over-year, from $5.79M to $8.7M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Aclaris Therapeutics ACRS Net Change in Cash

Net Change in Cash at other companies

IncyteINCY

$363.28M+43.1%

Corvus PharmaceuticalsCRVS

$35.53M+1,050%

Upstream Bio, Inc.UPB

-$4.85M+98.1%

Avalo TherapeuticsAVTX

$9.21M+197%

Shattuck Labs, Inc.STTK

$36.23M+932%

Apogee Therapeutics, Inc.APGE

$320.25M+1,018%

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's net change in cash?: Aclaris Therapeutics (ACRS) reported net change in cash of $8.7M in Q1 2026.
How has Aclaris Therapeutics's net change in cash changed year-over-year?: Aclaris Therapeutics's net change in cash increased by 50.3% year-over-year, from $5.79M to $8.7M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.